SPAC Translational Development closes $172.5M IPO; auditor flags going concern

Translational Development Acquisition Corp.

IPO of 17,250,000 units at $10.00/unit (including over-allotment), gross proceeds $172.5M.
Private placement of 7,075,000 warrants at $1.00 each to sponsor and underwriter, gross $7.075M.
Net proceeds $174,225,000 deposited into trust account; trust balance $174,225,000 as of Dec 24, 2024.
Auditor's going concern opinion: company lacks capital to sustain operations for one year from Dec 24, 2024.
Cash on hand $949,060; working capital $508,361; shareholders' deficit ($5,529,139).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.